Soluble flt-1 and the angiopoietins in the development and regulation of placental vasculature

被引:35
作者
Charnock-Jones, DS [1 ]
机构
[1] Univ Cambridge, Rosie Hosp, Dept Pathol, Reprod Mol Res Grp, Cambridge CB2 2SW, England
[2] Univ Cambridge, Rosie Hosp, Dept Obstet & Gynaecol, Reprod Mol Res Grp, Cambridge CB2 2SW, England
关键词
angiogenesis; endothelial cells; maturity; oxygen tension; vessel size;
D O I
10.1046/j.1469-7580.2002.00063.x
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
One of the key roles of the placenta is to mediate exchange of oxygen, nutrients and waste products between the maternal and fetal circulations. While some nutrients are actively taken up, oxygen is passively transported (i.e. it moves down a simple concentration gradient). To ensure an adequate supply as gestation progresses, the vascular structures in the human placenta remodel to facilitate this transfer. Under conditions in which oxygen is limited, at high altitude for example, these adaptations become more pronounced. In placentae obtained from high altitude the mean diameter of vessels is increased and the number of perivascular cells (pericytes) is reduced. Pericytes play an important role in modulating endothelial cell function and in their absence the endothelial cells are sensitive to growth factor withdrawal. The vascular remodelling that occurs in normal pregnancy is in part mediated by soluble factors (some produced by pericytes) and the level of these may in turn be regulated by local oxygen tension. We have shown that the mRNAs encoding both angiopoietins are present in the placenta and both are regulated by local pO(2). Ang-2 mRNA transcription is increased under reduced oxygen and the stability of Ang-1 mRNA is reduced under similar conditions. Thus the ratio of mRNAs encoding these antagonistic factors changes (in favour of Ang-2), in the placenta in response to a reduction in pO(2). The adaptations seen in the placenta and the mechanism by which they are achieved may be generally applicable.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 69 条
[1]  
Ahmed A, 1997, LAB INVEST, V76, P779
[2]  
Ali KZM, 1996, PLACENTA, V17, P677
[3]   Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness [J].
Athanassiades, A ;
Lala, PK .
PLACENTA, 1998, 19 (07) :465-473
[4]  
Benirschke K., 1990, PATHOLOGY HUMAN PLAC
[5]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[6]  
Benjamin LE, 1998, DEVELOPMENT, V125, P1591
[7]   EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS FLT AND KDR IN OVARIAN-CARCINOMA [J].
BOOCOCK, CA ;
CHARNOCKJONES, DS ;
SHARKEY, AM ;
MCLAREN, J ;
BARKER, PJ ;
WRIGHT, KA ;
TWENTYMAN, PR ;
SMITH, SK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :506-516
[8]   COORDINATE EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR RECEPTOR-1 (FLT-1) AND ITS LIGAND SUGGESTS A PARACRINE REGULATION OF MURINE VASCULAR DEVELOPMENT [J].
BREIER, G ;
CLAUSS, M ;
RISAU, W .
DEVELOPMENTAL DYNAMICS, 1995, 204 (03) :228-239
[9]   Stereological evaluation of vascular adaptations in human placental villi to differing forms of hypoxic stress [J].
Burton, GJ ;
Reshetnikova, OS ;
Milovanov, AP ;
Teleshova, OV .
PLACENTA, 1996, 17 (01) :49-55
[10]  
BURTON GJ, 1992, J DEV PHYSIOL, V18, P43